Cellular FLICE-like inhibitory protein protects against cardiac hypertrophy by blocking ASK1/p38 signaling in mice

Molecular and Cellular Biochemistry

Volumn 397, Issue 1-2, 2014, Pages 87-95

  Huang, Ying ^a   Wu, Lianpin ^b   Wu, Jian ^c,d   Li, Yumei ^a   Hou, Lili ^a  

^a SHANGHAI PULMONARY HOSPITAL   (China)

^b THE SECOND AFFILIATED HOSPITAL AND YUYING CHILDREN S HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

ASK1; Flip; Hypertrophy; Pressure overload

Indexed keywords

ANGIOTENSIN II; APOPTOSIS SIGNAL REGULATING KINASE 1; ATRIAL NATRIURETIC FACTOR; B TYPE NATRIURETIC FACTOR; FLICE INHIBITORY PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; NATRIURETIC FACTOR; PHENYLEPHRINE; UNCLASSIFIED DRUG; MAP3K5 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DOWN REGULATION; ECHOCARDIOGRAPH; ECHOCARDIOGRAPHY; ENZYME PHOSPHORYLATION; GENE INACTIVATION; HEART; HEART FUNCTION; HEART MUSCLE CELL; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; MOUSE MODEL; NEWBORN; NONHUMAN; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; CARDIOMEGALY; GENETICS; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY;

MUS;

ANIMALS; CARDIOMEGALY; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; DISEASE MODELS, ANIMAL; MAP KINASE KINASE KINASE 5; MAP KINASE SIGNALING SYSTEM; MICE; MICE, KNOCKOUT; P38 MITOGEN-ACTIVATED PROTEIN KINASES;

EID: 84912008723     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-014-2175-3     Document Type: Article

References (33)

1. Angermann CE, Stork S, Gelbrich G, Faller H, Jahns R, Frantz S, Loeffler M, Ertl G (2012) Mode of action and effects of standardized collaborative disease management on mortality and morbidity in patients with systolic heart failure: the interdisciplinary network for heart failure (INH) study. Circ Heart Fail 5(1):25–35. doi:10.1161/CIRCHEARTFAILURE.111.962969
2. Castagno D, Skali H, Takeuchi M, Swedberg K, Yusuf S, Granger CB, Michelson EL, Pfeffer MA, McMurray JJ, Solomon SD (2012) Association of heart rate and outcomes in a broad spectrum of patients with chronic heart failure: results from the CHARM (candesartan in heart failure: assessment of reduction in mortality and morbidity) program. J Am Coll Cardiol 59(20):1785–1795. doi:10.1016/j.jacc.2011.12.044
3. Kuusisto J, Karja V, Sipola P, Kholova I, Peuhkurinen K, Jaaskelainen P, Naukkarinen A, Yla-Herttuala S, Punnonen K, Laakso M (2012) Low-grade inflammation and the phenotypic expression of myocardial fibrosis in hypertrophic cardiomyopathy. Heart 98(13):1007–1013. doi:10.1136/heartjnl-2011-300960
4. Hu Y, Zhang H, Lu Y, Bai H, Xu Y, Zhu X, Zhou R, Ben J, Chen Q (2011) Class A scavenger receptor attenuates myocardial infarction-induced cardiomyocyte necrosis through suppressing M1 macrophage subset polarization. Basic Res Cardiol 106(6):1311–1328. doi:10.1007/s00395-011-0204-x
5. Cullen SP, Henry CM, Kearney CJ, Logue SE, Feoktistova M, Tynan GA, Lavelle EC, Leverkus M, Martin SJ (2013) Fas/CD95-induced chemokines can serve as “find-me” signals for apoptotic cells. Mol Cell 49(6):1034–1048. doi:10.1016/j.molcel.2013.01.025
6. Liu F, Bardhan K, Yang D, Thangaraju M, Ganapathy V, Waller JL, Liles GB, Lee JR, Liu K (2012) NF-kappaB directly regulates Fas transcription to modulate Fas-mediated apoptosis and tumor suppression. J Biol Chem 287(30):25530–25540. doi:10.1074/jbc.M112.356279
7. Priyadharshini B, Thornley TB, Daniels KA, Cuthbert A, Welsh RM, Greiner DL, Brehm MA (2013) Alloreactive CD8 T cells rescued from apoptosis during co-stimulation blockade by Toll-like receptor stimulation remain susceptible to Fas-induced cell death. Immunology 138(4):322–332. doi:10.1111/imm.12044
8. Werner AB, de Vries E, Tait SW, Bontjer I, Borst J (2002) TRAIL receptor and CD95 signal to mitochondria via FADD, caspase-8/10, Bid, and Bax but differentially regulate events downstream from truncated Bid. J Biol Chem 277(43):40760–40767. doi:10.1074/jbc.M204351200
9. Llobet D, Eritja N, Domingo M, Bergada L, Mirantes C, Santacana M, Pallares J, Macia A, Yeramian A, Encinas M, Moreno-Bueno G, Palacios J, Lewis RE, Matias-Guiu X, Dolcet X (2011) KSR1 is overexpressed in endometrial carcinoma and regulates proliferation and TRAIL-induced apoptosis by modulating FLIP levels. Am J Pathol 178(4):1529–1543. doi:10.1016/j.ajpath.2010.12.041
10. Chatterjee A, Mir SA, Dutta D, Mitra A, Pathak K, Sarkar S (2011) Analysis of p53 and NF-kappaB signaling in modulating the cardiomyocyte fate during hypertrophy. J Cell Physiol 226(10):2543–2554. doi:10.1002/jcp.22599
11. Li Y, Takemura G, Kosai K, Takahashi T, Okada H, Miyata S, Yuge K, Nagano S, Esaki M, Khai NC, Goto K, Mikami A, Maruyama R, Minatoguchi S, Fujiwara T, Fujiwara H (2004) Critical roles for the Fas/Fas ligand system in postinfarction ventricular remodeling and heart failure. Circ Res 95(6):627–636. doi:10.1161/01.RES.0000141528.54850.bd
12. Wollert KC, Heineke J, Westermann J, Ludde M, Fiedler B, Zierhut W, Laurent D, Bauer MK, Schulze-Osthoff K, Drexler H (2000) The cardiac Fas (APO-1/CD95) receptor/Fas ligand system: relation to diastolic wall stress in volume-overload hypertrophy in vivo and activation of the transcription factor AP-1 in cardiac myocytes. Circulation 101(10):1172–1178
13. Qiu L, Rivera-Perez JA, Xu Z (2011) A non-specific effect associated with conditional transgene expression based on Cre-loxP strategy in mice. PLoS ONE 6(5):e18778. doi:10.1371/journal.pone.0018778
14. Zhou B, Pu WT (2012) Genetic Cre-loxP assessment of epicardial cell fate using Wt1-driven Cre alleles. Circ Res 111(11):e276–e280. doi:10.1161/CIRCRESAHA.112.275784
15. Li L, Zhou N, Gong H, Wu J, Lin L, Komuro I, Ge J, Zou Y (2010) Comparison of angiotensin II type 1-receptor blockers to regress pressure overload-induced cardiac hypertrophy in mice. Hypertens Res 33(12):1289–1297. doi:10.1038/hr.2010.182
16. Zhou N, Li L, Wu J, Gong H, Niu Y, Sun A, Ge J, Zou Y (2010) Mechanical stress-evoked but angiotensin II-independent activation of angiotensin II type 1 receptor induces cardiac hypertrophy through calcineurin pathway. Biochem Biophys Res Commun 397(2):263–269. doi:10.1016/j.bbrc.2010.05.097
17. Wu J, Bu L, Gong H, Jiang G, Li L, Ma H, Zhou N, Lin L, Chen Z, Ye Y, Niu Y, Sun A, Ge J, Zou Y (2010) Effects of heart rate and anesthetic timing on high-resolution echocardiographic assessment under isoflurane anesthesia in mice. J Ultrasound Med 29(12):1771–1778
18. Wu J, Zhou YQ, Zou Y, Henkelman M (2013) Evaluation of bi-ventricular coronary flow patterns using high-frequency ultrasound in mice with transverse aortic constriction. Ultrasound Med Biol 39(11):2053–2065. doi:10.1016/j.ultrasmedbio.2013.04.022
19. Wu J, You J, Li L, Ma H, Jia J, Jiang G, Chen Z, Ye Y, Gong H, Bu L, Ge J, Zou Y (2012) Early estimation of left ventricular systolic pressure and prediction of successful aortic constriction in a mouse model of pressure overload by ultrasound biomicroscopy. Ultrasound Med Biol 38(6):1030–1039. doi:10.1016/j.ultrasmedbio.2012.01.018
20. Sano M, Minamino T, Toko H, Miyauchi H, Orimo M, Qin Y, Akazawa H, Tateno K, Kayama Y, Harada M, Shimizu I, Asahara T, Hamada H, Tomita S, Molkentin JD, Zou Y, Komuro I (2007) p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature 446(7134):444–448. doi:10.1038/nature05602
21. Imanishi T, Murry CE, Reinecke H, Hano T, Nishio I, Liles WC, Hofsta L, Kim K, O’Brien KD, Schwartz SM, Han DK (2000) Cellular FLIP is expressed in cardiomyocytes and down-regulated in TUNEL-positive grafted cardiac tissues. Cardiovasc Res 48(1):101–110
22. Matsukawa J, Matsuzawa A, Takeda K, Ichijo H (2004) The ASK1-MAP kinase cascades in mammalian stress response. J Biochem 136(3):261–265. doi:10.1093/jb/mvh134
23. Hou X, Hu Z, Huang X, Chen Y, He X, Xu H, Wang N (2013) Serum osteopontin, but not OPN gene polymorphism, is associated with LVH in essential hypertensive patients. J Mol Med (Berl). doi:10.1007/s00109-013-1099-9
24. Doetschman T, Azhar M (2012) Cardiac-specific inducible and conditional gene targeting in mice. Circ Res 110(11):1498–1512. doi:10.1161/CIRCRESAHA.112.265066
25. Frey N, Katus HA, Olson EN, Hill JA (2004) Hypertrophy of the heart: a new therapeutic target? Circulation 109(13):1580–1589. doi:10.1161/01.CIR.0000120390.68287.BB
26. Lorell BH, Carabello BA (2000) Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circulation 102(4):470–479
27. Panidis IP, Kotler MN, Ren JF, Mintz GS, Ross J, Kalman P (1984) Development and regression of left ventricular hypertrophy. J Am Coll Cardiol 3(5):1309–1320
28. Steenbergen C, Afshari CA, Petranka JG, Collins J, Martin K, Bennett L, Haugen A, Bushel P, Murphy E (2003) Alterations in apoptotic signaling in human idiopathic cardiomyopathic hearts in failure. Am J Physiol Heart Circ Physiol 284(1):H268–H276. doi:10.1152/ajpheart.00707.2002
29. Feng QZ, Zhao YS, Abdelwahid E (2008) The role of Fas in the progression of ischemic heart failure: prohypertrophy or proapoptosis. Coron Artery Dis 19(7):527–534. doi:10.1097/MCA.0b013e3283093707
30. Rohini A, Agrawal N, Koyani CN, Singh R (2010) Molecular targets and regulators of cardiac hypertrophy. Pharmacol Res 61(4):269–280. doi:10.1016/j.phrs.2009.11.012
31. Yip GW, Fung JW, Tan YT, Sanderson JE (2009) Hypertension and heart failure: a dysfunction of systole, diastole or both? J Hum Hypertens 23(5):295–306. doi:10.1038/jhh.2008.141
32. Micheau O, Lens S, Gaide O, Alevizopoulos K, Tschopp J (2001) NF-kappaB signals induce the expression of c-FLIP. Mol Cell Biol 21(16):5299–5305. doi:10.1128/MCB.21.16.5299-5305.2001
33. Badorff C, Ruetten H, Mueller S, Stahmer M, Gehring D, Jung F, Ihling C, Zeiher AM, Dimmeler S (2002) Fas receptor signaling inhibits glycogen synthase kinase 3 beta and induces cardiac hypertrophy following pressure overload. J Clin Invest 109(3):373–381. doi:10.1172/JCI13779